Search

Displaying results 5271 - 5280 of 10000 in total
  1. Target

    5-formyltetrahydrofolate cyclo-ligase

    go.drugbank.com/bio_entities/BE0001906
    TargetMycoplasma pneumoniae (strain ATCC 29342 / M129)

    Catalyzes the irreversible conversion of 5-formyltetrahydrofolate (5-FTHF) to yield 5,10-methenyltetrahydrofolate.

    Polypeptides: 5-formyltetrahydrofolate cyclo-ligaseFunction: 5-formyltetrahydrofolate cyclo-ligase activity
  2. Target

    Adenylate cyclase type 5

    go.drugbank.com/bio_entities/BE0003733
    TargetHumans

    Catalyzes the formation of the signaling molecule cAMP in response to G protein signaling (PubMed:15385642, PubMed:24700542, PubMed:26206488). Mediates signaling downstream of ADRB1 (PubMed:24700542). Regulates the increase of free cytos...

    Polypeptides: Adenylate cyclase type 5Synonyms: Adenylyl cyclase 5, ATP pyrophosphate-lyase 5
  3. Target

    Ribose-5-phosphate isomerase

    go.drugbank.com/bio_entities/BE0004438
    TargetHumans

    Catalyzes the reversible conversion of ribose-5-phosphate to ribulose 5-phosphate and participates in the first step of the non-oxidative branch of the pentose phosphate pathway

    Polypeptides: Ribose-5-phosphate isomerase
  4. Target

    Uridine 5'-monophosphate synthase

    go.drugbank.com/bio_entities/BE0004473
    TargetEnzymeHumans

    -5'-monophosphate decarboxylase (ODC), the terminal enzymatic reaction that decarboxylates OMP to uridine monophosphate (UMP) … Bifunctional enzyme catalyzing the last two steps of de novo pyrimidine biosynthesis, orotate phosphoribosyltransferase (OPRT), which converts orotate to orotidine-5'-monophosphate (OMP), and orotidine

    Polypeptides: Uridine 5'-monophosphate synthase
  5. Target

    5-hydroxytryptamine receptor 3C

    go.drugbank.com/bio_entities/BE0009584
    TargetHumans

    Forms serotonin (5-hydroxytryptamine/5-HT3)-activated cation-selective channel complexes, which when activated cause fast, depolarizing responses in neurons

    Polypeptides: 5-hydroxytryptamine receptor 3CSynonyms: 5-HT3C, 5-HT3-C
  6. Target

    5-hydroxytryptamine 3 receptor

    go.drugbank.com/bio_entities/BE0009860
    TargetHumans

    Forms serotonin (5-hydroxytryptamine/5-HT3)-activated cation-selective channel complexes, which when activated cause fast, depolarizing responses in neurons … Forms serotonin (5-hydroxytryptamine/5-HT3)-activated cation-selective channel complexes, which when activated cause fast, depolarizing responses in neurons

    Polypeptides: 5-hydroxytryptamine receptor 3A, 5-hydroxytryptamine receptor 3BSynonyms: 5-HT-3, 5-HT3A
  7. Target

    5-hydroxytryptamine receptor 3

    go.drugbank.com/bio_entities/BE0010272
    TargetHumans

    Forms serotonin (5-hydroxytryptamine/5-HT3)-activated cation-selective channel complexes, which when activated cause fast, depolarizing responses in neurons … Forms serotonin (5-hydroxytryptamine/5-HT3)-activated cation-selective channel complexes, which when activated cause fast, depolarizing responses in neurons

    Polypeptides: 5-hydroxytryptamine receptor 3A, 5-hydroxytryptamine receptor 3BSynonyms: 5-HT-3, 5-HT3A
  8. Drug

    Agomelatine

    go.drugbank.com/drugs/DB06594
    ApprovedInvestigational

    Agomelatine is a potent agonist at melatonin receptors and an antagonist at serotonin-2C (5-HT2C) receptors, tested in an animal model of depression. … It is currently sold in Australia under the Valdoxan trade name.

    Categories: Serotonin 5-HT2 Receptor Antagonists, Serotonin 5-HT2C Receptor AntagonistsProducts: VALDOXAN® 25 MG, VALDOXAN 25 MG
  9. Drug

    Fosinopril

    go.drugbank.com/drugs/DB00492
    ApprovedInvestigational

    ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). … Fosinopril is a phosphinic acid-containing ester prodrug that belongs to the angiotensin-converting enzyme (ACE) inhibitor class of medications.

    Mixtures: MONOPRIL PLUS 10 MG/12.5 MG TABLET, 28 ADET, MONOPRIL PLUS 20 MG/12.5 MG TABLET, 28 ADETCategories: Agents Acting on the Renin-Angiotensin System
  10. Drug

    alpha-Tocopherol succinate

    go.drugbank.com/drugs/DB14001
    ApprovedNutraceuticalVet approved

    The recommended dietary allowances (RDAs) for vitamin E alpha-tocopherol are: males = 4 mg (6 IU) females = 4 mg (6 IU) in ages 0-6 months, males = 5 mg (7.5 IU) females = 5 mg (7.5 IU) in ages 7-12 months … , males = 6 mg (9 IU) females = 6 mg (9 IU) in ages 1-3 years, males = 7 mg (10.4 IU) females = 7 mg (10.4 IU) in ages 4-8 years, males = 11 mg (16.4 IU) females = 11 mg (16.4 IU) in ages 9-13 years, males

    Synonyms: Vitamin E succinate, Vitamin E hemisuccinateMixtures: Formula Ma-vitamin E & Zinc Tab, Ni-C-E-LE Plus